Conceptio
›
Archive
›
bioRxiv / medRxiv
bioRxiv / medRxiv
open access
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Irajizad, E. et al.
· 2026
bioRxiv / medRxiv · Papers · License: Open Access · 2026
Open Source ↗
oncology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study
#668753
Antagonistic Pleiotropy at the HCAR1 Locus Reveals a Genetic Basis for Solid Tumor Resistance in Schizophrenia
#668754
Record
· ID 243510
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.